Atomo Diagnostics Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 17
Employees
  • Stock Symbol
  • AT1
Stock Symbol
  • Share Price
  • $0.06
  • (As of Friday Closing)

Atomo Diagnostics General Information

Description

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company develops point of care devices for rapid diagnostic testing. Its device is used to test infectious diseases including COVID-19, viral vs bacterial differentiation and female health. Its offers AtomoRapid RDP Platform with the device including Galileo, Pascal, Newton, Losev, Franklin and Elion. The firm operates in a single segment, being medical device research and development.

Contact Information

Website
www.atomodiagnostics.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Stock Exchange
ASX
Primary Office
  • Level 2, 701-703 Parramatta Road
  • Leichhardt
  • Sydney, New South Wales 2040
  • Australia
+61 (02) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atomo Diagnostics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.06 $0.06 $0.06 - $0.27 $34.6M 571M 1.13M

Atomo Diagnostics Financials Summary

In Thousands,
USD 		TTM 31-Mar-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 31-Dec-2019
EV 43,685 65,601 112,494
Revenue 5,007 1,320
EBITDA (3,568) (2,178)
Net Income (4,489) (6,174)
Total Assets 24,222 24,806 25,692
Total Debt 51 38 79
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Atomo Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atomo Diagnostics‘s full profile, request access.

Request a free trial

Atomo Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The
Diagnostic Equipment
Sydney, Australia
17 As of 2016
000.00
00.00 0000-00-00
00000000 000.00

0000000

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000000000 000000000
Yokne'am Illit, Israel
000.00
00.00 0000-00-00
000000&0

00000000

. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla paria
0000000000 000000000
Broomfield, CO
00 As of 0000
000
00.00 0000-00-00
000000000000 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atomo Diagnostics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PixCell Medical Technologies Formerly VC-backed Yokne'am Illit, Israel 000.00 000000&0
00000000 0000000 Private Equity-Backed Broomfield, CO 00 000 000000000000 000
000000 Corporation San Diego, CA 0000 00000000
00000-00000000 000 Private Equity-Backed Raritan, NJ 0000 00.000 000000&0 00.000
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
You’re viewing 5 of 17 competitors. Get the full list »

Atomo Diagnostics Patents

  • 47

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Atomo Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018348794-A1 Integrated blood test device Pending 12-Oct-2017 000000000
US-20210186390-A1 Integrated blood test device Pending 12-Oct-2017 000000000
EP-3713489-A1 Integrated blood test device Pending 12-Oct-2017 000000000
JP-2020536716-A Integrated blood test device Pending 12-Oct-2017 000000000
US-20190321823-A1 Integrated fluid module and test device Pending 11-Nov-2016 B01L3/502715
To view Atomo Diagnostics’s complete patent history, request access »

Atomo Diagnostics Executive Team (9)

Name Title Board Seat Contact Info
John Kelly Co-Founder, Chief Executive Officer & Board Member
Will Souter Chief Financial Officer
Chandra Sukumar Chief Operating Officer
Robert Snoch Group Financial Controller
Matthew Knill Director, International Sales
You’re viewing 5 of 9 executive team members. Get the full list »

Atomo Diagnostics Board Members (5)

Name Representing Role Since
Curt LaBelle MD Global Health Investment Fund Board Member 000 0000
Doris-Ann Williams Atomo Diagnostics Board Member 000 0000
George Sidis Atomo Diagnostics Board Member 000 0000
John Keith Atomo Diagnostics Chairman of the Board 000 0000
John Kelly Atomo Diagnostics Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Atomo Diagnostics’s complete board members history, request access »

Atomo Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial